NEWS: This superfood is now available in the SANEStore as a convenient whole-food powder so you can more easily enjoy it in smoothies and recipes.
Chaga Mushroom (non-GMO) is prized by natural health practitioners who consider it far superior to anything else in nature. The Chaga Mushroom has been appreciated for thousands of years, dating as far back as the 16th century traditionally used in Eastern European folk medicine as a possible natural remedy for a wide selection of conditions. Worldwide it is considered ‘The Medicinal King of Herbs’ and a precious gift from nature. Chaga Mushroom draws its nutrients out of living birch trees, rather than from the ground. The amazing properties of betulin or betulinic acid, a chemical isolated from birch trees, is now being studied for use as a chemotherapy agent. Chaga contains large amounts of betulinic acid in a form that can be ingested orally, as well as the full spectrum of immune-stimulating phytochemicals found in other medicinal mushrooms such as maitake mushroom and shiitake mushroom.
For centuries Traditional Chinese Medicine practitioners have used Chaga Mushroom for general health, longevity, beauty, and as a remedy for the most serious health conditions. In Asian culture, the Chaga Mushroom is referred to as the ‘Mushroom of Immortality’ used to support immunity, supporting the body’s ability to eliminate toxins while also supporting the nervous system. Raw Chaga Mushroom is a wonderful source of Melanin supporting youthful looks and vibrant skin. The Chaga Mushroom is known for its wonderful antioxidant properties and supporting a healthy inflammation response.
Today, the Chaga Mushroom is commonly used to support general health. Chaga Mushroom contains large amounts of phytonutrients and immune supporting compounds such as Beta Glycans and polysaccharides which may support the body’s ability to set up cellular defenses. It has even been said that the Chaga Mushroom can balance metabolism and one’s chi or vital energy levels.
The Chaga Mushroom is native to Western Siberia, Canada and USA and typically grows on the trunks of birch trees. Unlike other mushrooms with gills or caps, the Chaga has pores and is irregularly formed looking much like a burnt piece of charcoal. The Chaga is a parasitic mushroom that feeds on the white part of birch tree bark where the immune supporting substances are formed. This white part of the birch bark is also where the Chaga Mushroom obtains the powerful betulinic acid which may support the bodies fight of abnormal and uncontrolled cell division.
Raw Chaga Mushroom is 100% natural and harvested in the wild. It contain over 215 phytonutrients, has 25 to 50 times more SOD antioxidants than Agaricus, CoQ 10, vitamin C and wild blueberries, and is rated among the highest on the ORAC.
- High in immune supporting phytochemicals
- Supporting a healthy inflammatory response
- Incredibly high amounts of beta glucans, saponins, amino acids, betulinic acid, & natural minerals
- May support healthy Sleep
- May Protect against oxidation
- Supports the detoxification process of the body
- May support healthy blood pressure
- Anti-viral properties
- Abundance of B Vitamins
- Natural source of melanin supporting youthful looks & vibrant skin
- May reduce fatigue
- May support healthy mental function
- May support healthy digestion
- May Improve metabolism including activation of metabolism in cerebral tissue
- Supports a healthy cardiovascular & respiratory systems
- Supporting healthy blood glucose levels
- Reduction of gout
- Powerful anti-aging properties
- Excellent source of the enzyme SOD (Superoxide dismutase)
- Supports the central nervous & neurohumoral (they increase the activity of estrogens) systems of organism
1. “Inonotus obliquus (Ach. ex Pers.) Pilát 1942”. MycoBank. International Mycological Association. Retrieved 2011-10-11.
2. Needham, Arthur (2005-12-16). “Clinker Polypore, Chaga”. Retrieved 10 October 2011.
3. Muma, Walter. “True Tinder Fungus”. Retrieved 5 December 2012.
4. a b Müllauer, Franziska (2011). Betulinic Acid Induced Tumor Killing.
5. Yogeeswari, Perumal; Dharmarajan, Sriram (2005). “Betulinic Acid and Its Derivatives: A Review on their Biological Properties”. Current Medicinal Chemistry (12): 657–666.
6. “Abstractverwaltung Congrex”. Registration.akm.ch. Retrieved 2012-11-18.
7. Kathleen Blanchard (5 January 2011). “Betulin from birch bark could treat metabolic disorders”. EmaxHealth.
8. a b Piaskowski S. – Preliminary studies on the preparation and application of preparations from black birch touchwood in human cases of malignant tumors. Sylwan 105: 5-11, 1957.
9. a b Zheng, W. F.; Liu, T.; Xiang, X. Y.; Gu, Q. (July 2007). “Sterol composition in field-grown and cultured mycelia of Inonotus obliquus”. Yao xue xue bao = Acta pharmaceutica Sinica 42 (7): 750–756. PMID 17882960.
10. Zheng W, Miao K, Liu Y, Zhao Y, Zhang M, Pan S et al. (2010). “Chemical diversity of biologically active metabolites in the sclerotia of Inonotus obliquus and submerged culture strategies for up-regulating their production.”. Appl Microbiol Biotechnol 87 (4): 1237–54. doi:10.1007/s00253-010-2682-4. PMID 20532760.
11. Zheng, W. F. (July 2008). “Phenolic compounds from Inonotus obliquus and their immune-stimulating effects”. Mycosystema 27 (4): 574–581.
12. a b Song, Y.; Hui, J.; Kou, W.; Xin, R.; Jia, F.; Wang, N.; Hu, F.; Zhang, H. et al. (2008). “Identification of Inonotus obliquus and Analysis of Antioxidation and Antitumor Activities of Polysaccharides”. Current Microbiology 57 (5): 454–462. doi:10.1007/s00284-008-9233-6. PMID 18795365.
13. Tzianabos, Arthur O. (2000). “Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function”. Clinical Microbiology Reviews 13 (4): 523–533. doi:10.1128/CMR.13.4.523-533.2000. PMC 88946. PMID 11023954.
14. Chung, Mi Ja; Chung, Cha-Kwon; Jeong, Yoonhwa; Ham, Seung-Shi (June 2010). “Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells”. Nutrition Research and Practice 4 (3): 177–182. doi:10.4162/nrp.2010.4.3.177. PMC 2895696. PMID 20607061.
15. a b Park YM, Won JH, Kim YH, Choi JW, Park HJ, Lee KT (October 2005). “In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus”. J Ethnopharmacol 101 (1-3): 120–8. doi:10.1016/j.jep.2005.04.003. PMID 15905055.
16. a b Kim YO, Park HW, Kim JH, Lee JY, Moon SH, Shin CS (May 2006). “Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus”. Life Sci. 79 (1): 72–80. doi:10.1016/j.lfs.2005.12.047. PMID 16458328.
17. Dosychev, E. A.; Bystrova, V. N. (May 1973). “Treatment of psoriasis using “Chaga” fungus preparations”. Vestnik dermatologii i venerologii 47 (5): 79–83. PMID 4755970.
18. a b Paper with background on extraction processes
19. Rhee, S.Y. (2008). “A comparative study of analytical methods for alkali-soluble β-glucan in medicinal mushroom, Chaga (Inonotus obliquus)”. LWT – Food Science and Technology 41 (3): 545–549.
20. Rzymowska J (January 1998). “The effect of aqueous extracts from Inonotus obliquus on the mitotic index and enzyme activities”. Boll Chim Farm 137 (1): 13–5. PMID 9595828.
21. Cui Y, Kim DS, Park KC (January 2005). “Antioxidant effect of Inonotus obliquus”. J Ethnopharmacol 96 (1-2): 79–85. doi:10.1016/j.jep.2004.08.037. PMID 15588653.
22. Kim YO, Han SB, Lee HW, Ahn HJ, Yoon YD, Jung JK, Kim HM, Shin CS (September 2005). “Immuno-stimulating effect of the endo-polysaccharide produced by submerged culture of Inonotus obliquus”. Life Sci. 77 (19): 2438–56. doi:10.1016/j.lfs.2005.02.023. PMID 15970296.
23. Mizuno T. (1999). “Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus”. International Journal of Medicinal Mushrooms 1 (1): 301–316.
24. Anonymous. 2004. Cytotoxic effect of Inonotus obliquus composition in HCT-15 human colon and AGS gastric cancer cells. Journal of the Korean Society of Food Science and Nutrition. 33:633-640.
25. Alves, R. E., et al. 2002. Camu camu (Myrciaria dubia Mc Vaugh): a rich natural source of vitamin C. Proc. Interamer. Soc. Trop. Hort. 46:11-13.
26. Ajith, T. A. and K. K. Janardhanan. 2007. Indian medicinal mushrooms as a source of antioxidant and antitumor agents. J. Clin. Biochem. Nutr. 40:157.
27. Babitskaya, V. G,, Scherba, V. V., Ikonnikova, N.V., Bisko, N.A., and N.Y. Mitropoiskaya. 2002. Melanin complex from medicinal mushroom Inonotus obliquus (Pers:Fr.) Pilat (Chaga) (Aphyllophoromycetidae). Int. J. Med. Mushrooms. 4:139-45.
28. Bobek, P., Ozdin, L., and I. Kajaba. 1997. Dose-dependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Physiol Res. 47:327-329.
29. Bobek, P. and S. Galbavy. 1999. Hypocholesteremic and antiatherogenic effect of oyster mushroom (Pleurotus osteratus) in rabbits. Nahrung. 43:339-342.
30. Burczyk, J., Gawron, A. Slotwinska, M., Smietana, B., and K. Terminiska. 1996. Antimitotic activity of aqueous extracts of Inonotus obliquus. Boll. Chim. Farm. 135:306.
31. Chang, S. T. 1999. Global impact edible and medicinal mushrooms on human welfare in the 21st century: non-green evolution. Int. J. Med. Mushr. 1:1-7.
32. Chen, C., Zheng, W., Gao, X., Xiang, X., Sun, D., Wei, J., and C. Chu. 2007. Aqueous extract of Inonotus obliquus (Fr.) pilat (Hymenochaetaceae) significantly inhibits the growth of sarcoma 180 by inducing apoptosis. American Journal of Pharmacology and Toxicology. 2:10-17.
33. Chihara, G., Maeda, Y., Sasaki, T. and F. Fukuoaka. 1969. Inhibition of mouse sarcoma 180 by polysaccharides from Letin us eodes (Berk.) Nature. 222:687.
34. Chorvathova, V., et al. 1993. Effect of oyster fungus on glycemia and cholesterolaemia in rats with insluin-dependent diabetes. Physiol. Res. 42:175-179.
35.Cui, Yo, Kim, D. S., and K. C. Park. 2005. Antioxidant effects of Inonotus Oblique. J. Ethnopharmacol. 96:79-85.
36. de Sa, M. S., et al. 2009. Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciprum and in vivo in P. Berghel-infected mice. Parisitol. Res. Jul;105:275-279.
37. Fulda, S, et al. 1997. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of capases in neuroectodermal tumors. Cancer Research. 57:4956.
38. Fulda, S. 2008. Betulinic acid for cancer treatment and prevention. Int. J. Mol. Sci. 9:1096-1107.
39.Fulda, S., Jeremias, I., Pietsch, T. and K. M. Debatin. Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors. Klin Padiatr. 211:319-322.
40.Gu, Y. and S. Gowsala. 2006. Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells. J. Med. Food. 9:196-204.
41. Ham, S. S., et al. 2003. Antimutagenic and cytotoxic effects of ethanol extract from the Inonotus obliquus. J. Korean Soc. Food Sci. Nutr. 32:1088-94.
42. Hawksworth, D. L. 2001. Mushrooms: the extent of the unexplored potential. Int. J. Med. Mushr. 2:1-9.
43.Hossain, S., et al. 2003. Dietary mushroom (Pleurotus ostreatus) ameliorates atherogenic lipid in hypercholesterolaemic rats. Clin. Exp. Pharmacol. Physiol. 30:470-475.
44. Hyun, K. W., Jeong, S. C., Lee, D. H., Park, J. S., and J. S. Lee. 1996. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Boll. Chim. Farm. 135:306-309.
45.In-Kyoung, L., Young-Sook, K., Yoon-Woo, J., Jin-Young, J., and Y. Bong-Suk. 2007. New antioxidant polyphenols from the medicinal mushroom Inonotus obliquus. Bioorganic & Medicinal Chemistry Letters. 17:6678-6681.
46.Jeremias, I., et al. 2004. Cell death induction by betulinic acid, ceramide, and TRAIL in primary glioblastoma multiforme cells. Acta Neurochirurgica. 146:721-729.
47.Kahlos, K., Kangas, L., and R. Hiltunen. 1987. Antitumor activity of some compounds and fractions from an n-hexane extract of Inonotus obliquus in vitro. Acta Pharm. Fennica. 96:33-40.
48.Kharazmi, A. 2008. Laboratory and preclinical studies on the antiinflammatory and anti-oxidant properties of rosehip powder— identification and characterization of the active component GOPO. Osteoarhritis and Cartilage. 16:55-57.
49. Kim, B. K., Shin, G.G., Jeong, B.S., and J.Y. Cha. 2001. Cholesterol lowering effect of mushrooms powder in hyperlipidemic rats. J. Korean Soc. Food Sci. Nutr. 30:510-515.
50.Kim, Y. O., et al. 2005. Immuno-stimulatory effect of the endopolysaccharide produced by submerged culture of Inonotus obliquus. Life Sci. 77:2438-56.
51.Kim,Y. O., et al. 2006.Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci. 79:72-80.
52.Koyama, T., Yeunhwa, G., and T. Akira. 2008. Fungal medicine, Fuscoporia obliqua, as a traditional herbal medicine, in vivo testing and medicinal effects. Asian Biomedicine. 2:459-469.
53.Kraus-Zaki, J. 1957. (In Polish) ACTH jako czynnuk hydrolizujacy kwasy dezoksyrybonukleinowe w zastosowaniu do bada cytoenzymatycznych. Haematologica. 1:48-50.
54.Krauss-Zaki, J. 1962. Correspondence: Digestion of Cell Nucleus by Enzymes. Blood Journal. 19:527.
55.Lindequist, U., Niedermeyer, T. H. J., and W-D Julich. 2005. The pharmacological potential of mushrooms. Institute of Pharmacy, Greifswald, Germany.
56. Lull, C., Wichers, H. J., and H. F. J. Savelkoul. 2005. Antiinflammatory and immunomodulating properties of fungal metabolites (In) Mediators of Inflammation. Hindawi Publishing Corp.
57. McCord, J. M. and I. Fridovich. 1988. Superoxide dismutase: the first twenty years (1968-1988). Free Radic. Biol. Med. 5(5-6):363-369.
58. Mizuno, T., et al. 1999. Antitumor and hypoglycemic activities of polysaccharides from Sclerotia and mycelia of Inonotus obliquus. Int. J. Med. Mushrooms. 1:306.
59. Mizuno, T. 1999. The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan (review). Int. J. Med. Mushr. 1:9-30.
60.Mothana, R. A. A., Awadh, N. A. A., Jansen, R.,Wegner, U., Mentel, R., and U. Lindequist. 2003. Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi BRES Fitoteraia. 74:483-485.
61. Mullauer, F. B., Kessler, J. H., and J. P.Medema. Betulin is a potent antitumor agent that is enhanced by cholesterol. 2009. (by) Laboratory for Experimental Oncology and Radiology, PLoS One; 4(4).
62. Muller, F. L., et al. 2006. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 40:1993-2004.
63. Najafzadeh, M., et al. 2007. Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients. Biofactors. 31:191-200.
64. Nakagawa-Goto, K., Taniguchi, M., Tokuda, H., and K. H. Lee. 2008. Cancer preventive agents 9. Betulinic acid derivatives as potent cancer chemopreventive agents. Bioorg. Med. Chem. Lett. 1;19:3378-3381.
65. Nasar-Abbas, S. M. and A. Kadir Haikman. 2004. Antimicrobial effect of water extract of sumac (Rhus coriaria L.) on the growth of some food borne bacteria, including pathogens. J. Food Micro. 10:1016.
66. Nicolson, G. L., et al. 2000. Diagnosis and integrative treatment of intercelluar bacterial infections in chronic fatigue and fibromyalgia syndromes, GulfWar Illness, and rheumatoid arthritis and other chronic illnesses. Clin. Prac. Alt. Med. 1:92.
67. Nicolson, G. L. 2002. Co-infections in fibromyalgia syndrome, chronic fatigue syndrome, and other chronic illnesses. National Fibromyalgia Partnership—Fibromyalgia Frontiers. 10:5-9; 27-28.
68. Papas, A. M. (ed). 1999. Anitoxidant Status, Diet, Nutrition, and Health. Boca Raton: CRC Press. Park,Y. M., et al. 2005. In vivo and in vitro anti-inflammatory and antinociceptive effects of the methanol extract of Inonotus obliquus. J. Ethnopharmacol. 101:120-128.
69.Park,Y. M., et al. 2007. In vivo and in vitro anti-inflammatory and antinociceptive effects of the methanol extract of Inonotus obliquus. J. Med. Food. 10:80-90.
70. Rein, E., Kharazmi, A., and K. Winther. 2004. A herbal remedy, Hyben Vital (stand. Powder of Rosa canina fruits) reduces pain and improves general welbeing in patients with osteoarthritis- a double-blind, placebo controlled randomized trial. Phytomedicine. 11:383.
71. Rzymowska, J. 1996. The effect of aqueous extracts from Inonotus obliquus on the mitotic index and enzyme activities. Boll Chim. Farm. 135:306-309.
72.Sarkar, F. H. andY. Li. 2006. Using chemoprevention agents to enhance the efficacy of cancer therapy. Cancer Res. 66:3347.
73. Sawada, N., et al. 2004. Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice. British Cancer Journal. 90:1672.
74.Scott, Cyril. 1944. Health, Diet, and Common Sense. London: the Homeopathic Publishing Co.
75. Shin, Y., Tamai, Y., and M. Terazawa. 2000. Chemical constituents of Inonotus obliquus sclerotium. Eurasian Journal of Forest Research. 1:43-50.
76. Shivrina, A.N. 1967. Chemical characteristics of compounds extracted from Inonotus obliquus. Chem. Abstr. 66:17271-17279.
77. Sudhakar, C., Sabitha, P., Shashi, K. R. and S. Safe. 2007. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Research. 67:2816.
78. Sung, B., et al. 2008. Identification of a novel blocker of lkappaBalpha kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-kappaB. Mol. Cancer Ther. 7:19-201.
79. Takada, Y. and B. B. Aggarawal. 2003. Betulinic acid suppresses carcinogen-induced NF-kB activation through inhibition of lkappaB alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. Journal of Immunology. 171:3278.
80. Wang, H., Gao, J., and T. B. Ng. 2000. A new lectin with highly potent antihepatoma and antisarcoma activities from the oyster mushroom Pleurotus ostreatus. Biochem. Biophys. Res. Commun. 275:810-816.
81. Wick, W., Grimmel, C., Wagenknecht, B., Dichgans, J. and M. Weller. 1999. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reaction oxygen species, and caspase processing. J. Pharmacol. Exp. Ther. 289:1306- 1312.
82. Willmann, M. et al. 2009. Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound. Eur. J. Clin. Invest. 39:384.
83. Winther, K., Apel, K. and G. Thamsborg. 2005. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knew and hip osteoarhritis: A randomized, double-blind placebo controlled trial. Scand J. Rheumatol. 34:302.
84. Yesilada, E., et al. 1997. Inhibitory effects of Turkish folk remedies on inflammatory cytokin: interleukin-1 alpha, interleukin-1 beta, and tumor necrosis factor alpha. J. Ethnopharmacol. 58:59-73.
85. Ying-Mee, T., Yu, Rong, and J. M. Pezzuto. 2003. Betulinic acidinduced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Clinical Cancer Research. 9:2866.